Candriam SCA’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-969
| Closed | -$418K | – | 797 |
|
|
2019
Q3 | $418K | Hold |
969
| – | – | 0.01% | 699 |
|
|
2019
Q2 | $1.15M | Buy |
969
+235
| +32% | +$279K | 0.01% | 625 |
|
|
2019
Q1 | $915K | Buy |
+734
| New | +$915K | 0.01% | 649 |
|
|
2017
Q2 | – | Sell |
-1,600
| Closed | -$869K | – | 710 |
|
|
2017
Q1 | $869K | Hold |
1,600
| – | – | 0.02% | 585 |
|
|
2016
Q4 | $976K | Hold |
1,600
| – | – | 0.02% | 519 |
|
|
2016
Q3 | $1.14M | Hold |
1,600
| – | – | 0.03% | 470 |
|
|
2016
Q2 | $1.16M | Sell |
1,600
-499
| -24% | -$363K | 0.03% | 409 |
|
|
2016
Q1 | $1.24M | Sell |
2,099
-101
| -5% | -$59.9K | 0.03% | 395 |
|
|
2015
Q4 | $1.26M | Hold |
2,200
| – | – | 0.03% | 361 |
|
|
2015
Q3 | $1.23M | Sell |
2,200
-150
| -6% | -$84K | 0.03% | 411 |
|
|
2015
Q2 | $1.87M | Hold |
2,350
| – | – | 0.04% | 373 |
|
|
2015
Q1 | $1.96M | Hold |
2,350
| – | – | 0.04% | 390 |
|
|
2014
Q4 | $1.69M | Buy |
+2,350
| New | +$1.69M | 0.04% | 378 |
|